Advertisement
Screener

AVENIR WELLNESS SOLUTIONS, INC. Patents: Expired

AVENIR WELLNESS SOLUTIONS, INC. Expired Patents

5 granted patents the USPTO lists as expired; the status gives the reason, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.

  • 2020-04-23: Application 16856609; Invention PHARMACEUTICAL COMPOSITION AND METHOD OF MANUFACTURING; Applicant CURE PHARMACEUTICAL HOLDING CORP.; Status Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.362.
  • 2020-04-23: Application 16856492; Invention PHARMACEUTICAL COMPOSITION AND METHOD OF MANUFACTURING; Applicant CURE PHARMACEUTICAL HOLDING CORP.; Status Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.362.
  • 2020-03-05: Application 16809958; Invention PHARMACEUTICAL COMPOSITION AND METHOD OF MANUFACTURING; Applicant CURE PHARMACEUTICAL HOLDING CORP.; Status Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.362.
  • 2019-07-11: Application 16508637; Invention RAPIDLY DISINTEGRATING ORAL DISSOLVABLE FILM; Applicant CURE Pharmaceutical Holding Corp.; Status Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.362.
FiledApplicationInventionApplicantStatusGrantedPatentPublished asInventor nameInventor countryExaminer
2020-04-2316856609PHARMACEUTICAL COMPOSITION AND METHOD OF MANUFACTURINGCURE PHARMACEUTICAL HOLDING CORP.Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.3622022-05-1711331358US20200246406A1
Gary J. Speier
United States
MELLER, MICHAEL V
2020-04-2316856492PHARMACEUTICAL COMPOSITION AND METHOD OF MANUFACTURINGCURE PHARMACEUTICAL HOLDING CORP.Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.3622022-05-3111344591US20200246405A1
Gary J. Speier
United States
MELLER, MICHAEL V
2020-03-0516809958PHARMACEUTICAL COMPOSITION AND METHOD OF MANUFACTURINGCURE PHARMACEUTICAL HOLDING CORP.Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.3622022-03-0811266702US20200215137A1
Gary J. Speier
United States
MELLER, MICHAEL V
2019-07-1116508637RAPIDLY DISINTEGRATING ORAL DISSOLVABLE FILMCURE Pharmaceutical Holding Corp.Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.3622022-05-3111344506US20200016092A1
Jose Bernardo
Vered Gigi
United States
United States
FALKOWITZ, ANNA R
2019-06-0516432443METHODS AND COMPOSITIONS FOR IMPROVING SLEEPCURE Pharmaceutical Holding Corp.Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.3622022-05-1711331309US20200383962A1
Jose Bernardo
United States
CHONG, YONG SOO